Literature DB >> 20943236

Mitochondrial dementia: a sporadic case of progressive cognitive and behavioral decline with hearing loss due to the rare m.3291T>C MELAS mutation.

Ettore Salsano1, Anna Rita Giovagnoli, Lucia Morandi, Carmelo Maccagnano, Eleonora Lamantea, Chiara Marchesi, Massimo Zeviani, Davide Pareyson.   

Abstract

We report the case of a 23-year-old Italian female harboring the rare m.3291T>C mutation in the MT-TL1 gene, that encodes the mitochondrial transfer RNA for leucine 1 (UUA/G). MT-TL1 mutations usually cause the MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes) syndrome. Our patient, however, suffered from a non-syndromic mitochondrial disorder (MID), clinically characterized by progressive cognitive and behavioral decline, and hearing loss; brain MRI disclosed diffuse supratentorial and infratentorial atrophy; EKG revealed a Wolff-Parkinson-White syndrome; combined neuroleptic and antidepressant treatment markedly improved her behavioral symptoms. This case expands the clinical spectrum of non-syndromic MIDs, and further confirms that no obvious genotype-phenotype correlation exists for the m.3291T>C DNA mutation; indeed, this mutation has been previously reported in a Japanese child, who suffered from MELAS, and in an Italian child, who presented an apparently isolated mild myopathy. Moreover, it supports the hypothesis that at least in MT-TL1-related MIDs, dementia may be caused by a progressive neurodegenerative process, rather than by injury accumulation due to stroke-like episodes. Finally, our case suggests that common neuroleptic and antidepressant drugs may be clinically efficacious in the management of psychiatric symptoms associated with MIDs.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20943236     DOI: 10.1016/j.jns.2010.09.022

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

Review 1.  Clinical neurogenetics: recent advances.

Authors:  Davide Pareyson; Ettore Salsano
Journal:  J Neurol       Date:  2012-07-21       Impact factor: 4.849

2.  MERRF/MELAS overlap syndrome due to the m.3291T>C mutation.

Authors:  Kaiming Liu; Hui Zhao; Kunqian Ji; Chuanzhu Yan
Journal:  Metab Brain Dis       Date:  2013-12-12       Impact factor: 3.584

3.  Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation.

Authors:  Kristina Leuner; Tanja Schütt; Christopher Kurz; Schamim H Eckert; Carola Schiller; Angelo Occhipinti; Sören Mai; Marina Jendrach; Gunter P Eckert; Shane E Kruse; Richard D Palmiter; Ulrich Brandt; Stephan Dröse; Ilka Wittig; Michael Willem; Christian Haass; Andreas S Reichert; Walter E Müller
Journal:  Antioxid Redox Signal       Date:  2012-02-28       Impact factor: 8.401

Review 4.  From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease.

Authors:  Kristina Leuner; Walter E Müller; Andreas S Reichert
Journal:  Mol Neurobiol       Date:  2012-07-26       Impact factor: 5.590

5.  The m.3291T>C mt-tRNA(Leu(UUR)) mutation is definitely pathogenic and causes multisystem mitochondrial disease.

Authors:  John W Yarham; Emma L Blakely; Charlotte L Alston; Mark E Roberts; John Ealing; Piyali Pal; Douglass M Turnbull; Robert McFarland; Robert W Taylor
Journal:  J Neurol Sci       Date:  2012-12-27       Impact factor: 3.181

6.  Variable phenotypes in a family with mitochondrial encephalomyopathy harboring a 3291T > C mutation in mitochondrial DNA.

Authors:  Yoko Sunami; Keizo Sugaya; Norio Chihara; Yu-ichi Goto; Shiro Matsubara
Journal:  Neurol Sci       Date:  2011-08-24       Impact factor: 3.307

7.  The expanding phenotype of MELAS caused by the m.3291T > C mutation in the MT-TL1 gene.

Authors:  E Keilland; C A Rupar; Asuri N Prasad; K Y Tay; A Downie; C Prasad
Journal:  Mol Genet Metab Rep       Date:  2016-02-22

8.  Endogenous reactive oxygen species cause astrocyte defects and neuronal dysfunctions in the hippocampus: a new model for aging brain.

Authors:  Takamasa Ishii; Yumi Takanashi; Koichi Sugita; Masaki Miyazawa; Rintaro Yanagihara; Kayo Yasuda; Hiromi Onouchi; Noboru Kawabe; Munehiro Nakata; Yorihiro Yamamoto; Phil S Hartman; Naoaki Ishii
Journal:  Aging Cell       Date:  2016-09-13       Impact factor: 9.304

9.  Cognitive Profile of Patients With Mitochondrial Chronic Progressive External Ophthalmoplegia.

Authors:  Guanyu Zhang; Yue Hou; Zhaoxia Wang; Zheng Ye
Journal:  Front Neurol       Date:  2020-01-29       Impact factor: 4.003

10.  Systematic review of cognitive deficits in adult mitochondrial disease.

Authors:  H L Moore; A P Blain; D M Turnbull; G S Gorman
Journal:  Eur J Neurol       Date:  2019-10-22       Impact factor: 6.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.